New Search

Refine your search within these categories:

1. Human Genes (group results)

2. Interaction: Human Genes and Chemicals (group results)

3. Bioactivity

4. Semantic Terms (group results)

A. Anatomy (group results)

B. Organisms

C01. Bacterial Infections and Mycoses (group results)

C02. Virus Diseases (group results)

C03. Parasitic Diseases (group results)

C04. Neoplasms (group results)

C05. Musculoskeletal Diseases (group results)

C06. Digestive System Diseases (group results)

C07. Stomatognathic Diseases (group results)

C08. Respiratory Tract Diseases (group results)

C09. Otorhinolaryngologic Diseases (group results)

C10. Nervous System Diseases (group results)

C11. Eye Diseases (group results)

C12. Male Urogenital Diseases (group results)

C13. Female Urogenital Diseases and Pregnancy Complications (group results)

C14. Cardiovascular Diseases (group results)

C15. Hemic and Lymphatic Diseases (group results)

C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities: all > Congenital, Hereditary, and Neonatal Diseases and Abnormalities [MESH:D009358] > Congenital Abnormalities [MESH:D000013] > Nervous System Malformations [MESH:D009421] > Malformations of Cortical Development [MESH:D054220] > Microcephaly [MESH:D008831] > Hoyeraal Hreidarsson syndrome [MESH:C536068]

C17. Skin and Connective Tissue Diseases (group results)

C18. Nutritional and Metabolic Diseases (group results)

C19. Endocrine System Diseases (group results)

C20. Immune System Diseases (group results)

C21. Disorders of Environmental Origin (group results)

C22. Animal Diseases (group results)

C23. Pathological Conditions, Signs and Symptoms (group results)

C24. Occupational Diseases (group results)

C25. Chemically-Induced Disorders: all > Substance-Related Disorders [MESH:D019966] > Marijuana Abuse [MESH:D002189]

C26. Wounds and Injuries (group results)

D01. Inorganic Chemicals (group results)

D02. Organic Chemicals (group results)

D03. Heterocyclic Compounds (group results)

D04. Polycyclic Compounds (group results)

D05. Macromolecular Substances

D06. Hormones, Hormone Substitutes, and Hormone Antagonists (group results)

D08. Enzymes and Coenzymes

D09. Carbohydrates (group results)

D10. Lipids (group results)

D12. Amino Acids, Peptides, and Proteins (group results)

D13. Nucleic Acids, Nucleotides, and Nucleosides (group results)

D20. Complex Mixtures (group results)

D23. Biological Factors (group results)

D25. Biomedical and Dental Materials

D26. Pharmaceutical Preparations (group results)

D27. Chemical Actions and Uses (group results)

E. Analytical, Diagnostic and Therapeutic Techniques and Equipment (group results)

F. Psychiatry and Psychology (group results)

G. Phenomena and Processes (group results)

I. Anthropology, Education, Sociology and Social Phenomena

J. Technology, Industry, Agriculture (group results)

N. Health Care

Recently Viewed Items
 
These terms define your current search. Click the
×
to remove a term.

C25. Chemically-Induced Disorders: Substance-Related Disorders [MESH:D019966] > Marijuana Abuse [MESH:D002189]
×

Items 1 to 40 of 100 results
Group by: C16. Congenital, Hereditary, and Neonatal Diseases and Abnormalities, C25. Chemically-Induced Disorders
Sort by: MeSH_UID, MeSH_NAME
 
1
41
81
MESH:C005961
 bis(tri-n-butyltin)oxide
C005961
 
  
  
  
MESH:C006253
 pirinixic acid
C006253
 
  
  
  
MESH:C006632
 arsenic trioxide
C006632
 
  
  
  
MESH:C006780
 bisphenol A
C006780
 
  
  
  
MESH:C007517
 diphenyleneiodonium
C007517
 
  
  
  
MESH:C008493
 methylselenic acid
C008493
 
  
  
  
MESH:C009505
 4,4'-diaminodiphenylmethane
C009505
 
  
  
  
MESH:C012589
 trichostatin A
C012589
 
  
  
  
MESH:C013592
 mangiferin
C013592
 
  
  
  
MESH:C014347
 decitabine
C014347
 
  
  
  
MESH:C016403
 2,4-dinitrotoluene
C016403
 
  
  
  
MESH:C016583
 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone
C016583
 
  
  
  
MESH:C016601
 afimoxifene
C016601
 
  
  
  
MESH:C016837
 zinc chloride
C016837
 
  
  
  
MESH:C017947
 sodium arsenite
C017947
 
  
  
  
MESH:C018021
 cobaltous chloride
C018021
 
  
  
  
MESH:C023036
 perfluorooctanoic acid
C023036
 
  
  
  
MESH:C029497
 2,3-bis(3'-hydroxybenzyl)butyrolactone
C029497
 
  
  
  
MESH:C033607
 puerarin
C033607
 
  
  
  
MESH:C039281
 furan
C039281
 
  
  
  
MESH:C045037
 testosterone-3-carboxymethyloxime-bovine serum albumin conjugate
C045037
 
  
  
  
MESH:C045651
 epigallocatechin gallate
C045651
 
  
  
  
MESH:C047246
 temozolomide
C047246
 
  
  
  
MESH:C053541
 bicalutamide
C053541
 
  
  
  
MESH:C056507
 gemcitabine
C056507
 
  
  
  
MESH:C057693
 troglitazone
C057693
 
  
  
  
MESH:C059514
 resveratrol
C059514
 
  
  
  
MESH:C061365
 flusilazole
C061365
 
  
  
  
MESH:C061481
 dibenzoylmethane
C061481
 
  
  
  
MESH:C070081
 fulvestrant
C070081
 
  
  
  
MESH:C074702
 chromium hexavalent ion
C074702
 
  
  
  
MESH:C085911
 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one
C085911
 
  
  
  
MESH:C090942
 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole
C090942
 
  
  
  
MESH:C093642
 SB 203580
C093642
 
  
  
  
MESH:C103303
 alitretinoin
C103303
 
  
  
  
MESH:C113580
 U 0126
C113580
 
  
  
  
MESH:C406082
 monomethylarsonous acid
C406082
 
  
  
  
MESH:C419708
 gefitinib
C419708
 
  
  
  
MESH:C432165
 anthra(1,9-cd)pyrazol-6(2H)-one
C432165
 
  
  
  
MESH:C434003
 3-(4-methylphenylsulfonyl)-2-propenenitrile
C434003
 
  
  
  
1
41
81